secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001193125-25-151234
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve amendment to CalciMedica 2023 equity plan, adding 600,000 shares
--------------------------------------------------------------------------------

- Stockholders elected all three Class I director nominees: Leheny, Roberts, Guerard with over 9.5M votes each.
- Ratification of Baker Tilly as independent auditor for FY 2025 passed with 12.3M votes for, 135K against.
- Amendment to 2023 Equity Incentive Plan approved (8.9M for, 923K against), increasing authorized shares by 600,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525151234/0001193125-25-151234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525151234/d12150d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-151234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer